Pfizer says any merger of the two companies would see the ... last week which saw the Novartis swap its vaccines business for GSK's oncology franchise. In the age of AI, large data sets ...

Pfizer and GSK plan to divest the business completely ... and the deal was instantly controversial in both Europe and the US. The merger would have created the biggest pharmaceutical company ...

Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...

Parke-Davis (India) in the near future is unlikely to get five major products which Glaxo Wellcome worldwide ... The operational merger between Pfizer and Parke-Davis has been completed and ...

The defence giant employs 1,350 people at its site in Marconi Way, a namecheck to its previous existence before the merger ... BASF, Pfizer, RWE, E.ON, Vattenfall and GlaxoSmithKline.

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does not admit to any liability in ...

Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns Sept 18 (Reuters ...

Kimbrow, 73, said he took Zantac from 1995 to 2019. Boehringer Ingelheim, GSK, Pfizer and Sanofi all sold brand name Zantac at various times since it was approved in 1983, and have been named in ...

Among adults aged 60 years and older, the societal cost per QALY saved was $196,842 for GSK’s Arexvy and $178,557 for Pfizer’s Abrysvo. 1 For adults aged 65 years and older, the cost was $ ...